Core Viewpoint - Dongcai Fund Management Co., Ltd. is participating in a fee discount activity for fund subscription and purchase through Aijian Securities to better meet investors' financial needs [1]. Group 1: Applicable Time - The fee discount period is subject to the announcement by Aijian Securities [1]. Group 2: Applicable Fund Range - The fee discount activity applies to fund products sold by Dongcai Fund through Aijian Securities from the date the fund is available for sale [2]. Group 3: Fee Discount Plan - During the fee discount period, there are no discount limits on subscription and purchase fees for investors through Aijian Securities, with specific discount rates to be announced by Aijian Securities [3]. Group 4: Applicable Investors - The fee discount is available to investors who subscribe or purchase the aforementioned funds through Aijian Securities [4]. Group 5: Important Notes - Detailed information about the funds and original fee rates can be found in the relevant legal documents and announcements from the company [5][6]. - Any changes to the fee discount plan and applicable time will be based on the latest announcements from Aijian Securities [5]. Group 6: Contact Information - Investors can consult details through Dongcai Fund Management Co., Ltd. or Aijian Securities via their respective customer service numbers and websites [7][10].

Group 1 - The fund being launched is called "Zhongshan Medical Quantitative Stock Selection Mixed Initiation Securities Investment Fund" [25] - The fund is a mixed-type open-ended securities investment fund [2][25] - The fund's management company is China Merchants Fund Management Co., Ltd. and the custodian is Everbright Securities Co., Ltd. [2][25] Group 2 - The fund will be publicly offered from December 17, 2025, to December 26, 2025, with the possibility of adjusting the fundraising period based on subscription conditions [2][30] - The initial fundraising scale is capped at 3 billion RMB (approximately 30 billion) [3][27] - If the subscription amount reaches or exceeds 3 billion RMB, the fund may end the fundraising early [4][28] Group 3 - The fund is open to individual investors, institutional investors, qualified foreign investors, and other investors permitted by laws and regulations [6][29] - The fund has two classes of shares: Class A and Class C, with different fee structures [26][33] - The minimum subscription amount for Class A shares is 500,000 RMB through direct sales, while for Class C shares, it is 1 RMB [39][32] Group 4 - Investors can make multiple subscriptions during the fundraising period, and the subscription fee for Class A shares is calculated separately for each application [9][38] - The fund's subscription price is set at an initial value of 1.00 RMB per share [32][27] - The fund will provide interest on effective subscription amounts during the fundraising period, which will be converted into fund shares [12][36]

Group 1 - The core viewpoint is that with the backdrop of the Federal Reserve's interest rate cuts, global funds are increasingly favoring Chinese assets due to the resilience of the Chinese economy, attractive market valuations, and an improving policy environment [1][2] - Foreign long-term capital is actively reassessing the investment value of Chinese assets, particularly in technology stocks, with a focus on structural growth opportunities over the next 10 to 20 years [2] - As of November this year, foreign long-term capital has net purchased approximately $10 billion in A-shares and H-shares through channels like the Shanghai-Hong Kong Stock Connect, contrasting sharply with an expected outflow of about $17 billion in 2024 [1] Group 2 - In December, Chinese stock funds saw a net inflow of $5.846 billion, surpassing markets like South Korea and India [1] - The assets of overseas Chinese ETFs have significantly increased, with the KraneShares China Internet ETF growing from $5.414 billion at the end of last year to $8.914 billion, and the iShares MSCI China ETF rising from $5.451 billion to $7.878 billion [1] - Multiple foreign institutions believe that the Chinese stock market has entered an attractive configuration zone, with expectations of continued rebound potential through 2026 due to improving macro conditions and corporate resilience [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 [重要提示] 1、平安港股通均衡配置混合型证券投资基金（以下简称"本基金"）的发售已获中国证监会2025年11月 28日证监许可【2025】2622号文注册。中国证监会对本基金的注册并不代表中国证监会对本基金的投资 价值和市场前景作出实质性判断或保证，也不表明投资于本基金没有风险。 7、本基金首次募集规模上限为10亿元人民币（不包括募集期利息，下同）。在募集期内任何一日（含 首日，T日），若预计T日的有效认购申请全部确认后，本基金募集总规模（以有效认购金额计算，不 含募集期间利息）接近、达到或超过募集规模上限，基金管理人将采取末日比例确认的方式实现规模的 有效控制，本基金可于T+1日提前结束募集，自T+1日起（含）不再接受认购申请。 当发生末日比例确认时，基金管理人将及时公告比例确认情况与结果。未确认部分的认购款项本金将在 募集期结束后退还给投资者，由此产生的利息等损失由投资人自行承担。 末日认购申请确认比例的计算方法如下： 末日认购申请确认比例＝（10亿元－末日之前有效认购申请金额总额）/末日有效认购申请金额总额 末日投资者认购申请确认金额=末日提交的有效认 ...

Group 1 - The announcement states that Yingda Fund Management Co., Ltd. has updated the prospectus and product summary for several funds, which will be disclosed on December 11, 2025, on the company's website and the China Securities Regulatory Commission's fund disclosure website [1] - The company has signed a fund sales agency agreement with GF Securities Co., Ltd., allowing GF Securities to act as a sales institution for certain funds starting from December 11, 2025 [2] Group 2 - Investors can conduct various fund-related transactions, including account opening, subscription, redemption, and regular investment through GF Securities, and can also participate in fee discount activities offered by GF Securities [2] - The announcement includes a section on fee discount activities for investors who subscribe to the listed funds through GF Securities, with specific discount rates and periods to be confirmed by GF Securities [4]

Vaccine ETFs - There are two ETFs named Vaccine ETF, one managed by Guotai Fund tracking the Guozheng Vaccine and Biotechnology Index, consisting of 50 companies in the biotechnology sector with an average market capitalization of approximately 54.5 billion CNY [1] - The second Vaccine ETF is managed by Harvest Fund, tracking the CSI Vaccine and Biotechnology Index, which includes up to 50 companies involved in vaccine research and production, with 43 constituent stocks and an average market capitalization of about 20.5 billion CNY [2] - The overlap between the two indices includes 19 common stocks, with 31 unique to the Guozheng index and 24 unique to the CSI index [3] - The historical performance shows that the CSI Vaccine and Biotechnology Index has outperformed the Guozheng index in annualized returns over the past year, three years, and five years, although both indices have negative returns over the last three and five years [5] - The CSI index has a higher annualized volatility compared to the Guozheng index [5] Satellite ETFs - There are two ETFs named Satellite ETF, one managed by Yongying Fund tracking the Guozheng Commercial Satellite Communication Industry Index, which includes 50 companies with an average market capitalization of approximately 38.6 billion CNY [9] - The second Satellite ETF is managed by Fortune Fund, tracking the CSI Satellite Industry Index, which also consists of 50 companies with an average market capitalization of about 26.6 billion CNY [10] - Both indices share 28 common stocks, with each having 22 unique stocks [11] - The Guozheng Commercial Satellite Communication Industry Index has outperformed the CSI Satellite Industry Index in annualized returns over the past year and three years, while the CSI index has outperformed in the five-year period [12][13] - The annualized volatility of both indices is relatively similar across one, three, and five years [13] - The valuation levels indicate that the Guozheng index's TTM P/E ratio is at the historical 100th percentile, while the CSI index's TTM P/E ratio is above the 90th percentile [15][17]

Core Insights - The 13th China Responsible Investment Forum highlighted the shift of sustainable development from merely an environmental issue to a core financial, economic, and investment topic [1][21] - Climate and nature-related impacts are increasingly recognized as financial risks, necessitating a focus on adaptation and resilience as key investment themes [5][25] Group 1: Emerging Investment Frontiers - New markets are emerging in digitalization and AI monitoring, with companies like Pachama and OroraTech utilizing satellite data and AI to quantify forest carbon storage and land degradation in real-time [6][27] - Digital monitoring has become an investment theme itself, providing credible measurements and enhancing market confidence as data accumulates [7][27] Group 2: Natural and Ecosystem Markets - Financing for nature and biodiversity is becoming a new asset class, with growing investor interest in biodiversity-linked tools, ecological restoration projects, and natural capital valuation [8][29] - COP30 emphasized the rising global focus on ecosystem restoration and natural financing, particularly in Asia, where China is positioned to develop these markets more rapidly than other regions [9][29] Group 3: Infrastructure and Resilience Financing - Adaptive and resilient infrastructure represents a significant future capital demand, including water systems, resilient urban infrastructure, and disaster-resistant supply chains [10][30] - Early examples of resilience financing at the sovereign and industry levels, such as the Caribbean Disaster Risk Insurance Facility, demonstrate how parametric insurance can provide liquidity post-climate disasters [10][28] Group 4: Health Resilience as a New Financial Market - The integration of climate, nature, and health is emerging as a significant trend, with capital flowing into health security and resilience [11][29] - Initiatives like pandemic funds are financing early warning systems and health monitoring infrastructure in emerging economies, marking the emergence of a new asset class in health resilience [11][29] Group 5: Implications for Finance and Business - The financial industry must support capital allocation for adaptation, resilience building, natural financing, and health security solutions [12][30] - Asia's unique advantages, including policy frameworks and financial platforms, position it to scale investments more rapidly than other regions, with China's progress in transforming financial and market infrastructure drawing attention at COP30 [12][30] Group 6: New Strategic Directions - The shift in investment logic is moving from managing climate risks to designing for resilient growth, integrating climate, nature, health, and digital innovation to create value [13][31] - The current challenge lies in fostering collaboration across public and private sectors, financial and corporate realms, and international borders to build the next phase of sustainable and resilient growth [14][32]

中国经济网北京12月11日讯 今日，上海光大证券资产管理发布光大阳光稳债收益12个月持有期债券型集 合资产管理计划清算报告。 | | 今年来 近1周 近1月 近3月 近6月 近1年 近2年 近3年 近5年 成立来 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 涨幅 1.10% | | 0.00% | -0.01% | 0.28% | 0.26% | 1.34% | 5.02% | 8.66% | 15.95% | 16.25% | | 同类平均� 2.57% | | 0.09% | -0.28% | 0.50% | 1.38% | 2.91% | 8.21% | 10.83% | 20.09% | | | 沪深300 16.69% | 35.08% | 1.34% | -2.20% | 3.29% | 18.79% | 14.92% | | 14.85% | -7.06% | | 光大阳光稳债收益12个月持有债券C累计收益率 | | | | | | | 今年来 近1周 近1月 ...

公司官网：www.abc-ca.com（CIS） 风险提示：基金有风险，投资需谨慎。农银汇理基金旗下产品由农银汇理基金管理有限公司发行与管 理，代销机构不承担产品的投资和兑付责任。基金管理人承诺以诚实信用、勤勉尽职的原则管理和运用 基金资产，但不保证基金一定盈利，也不保证最低收益，可能存在本金损失的风险。基金过往业绩及其 净值高低并不预示其未来表现，基金管理人管理的其它基金的业绩并不构成基金业绩表现的保证。基金 投资于证券市场，基金净值会因证券市场波动等因素产生波动。农银汇理基金管理有限公司提示您基金 投资的"买者自负"原则，在做出投资决策后，基金运营状况与基金净值变化引致的投资风险，由您自行 负担。基金管理人、基金托管人、基金销售机构及相关机构不对基金投资收益做出任何承诺或保证。请 您在投资前认真阅读《基金合同》、《基金招募说明书》及《基金产品资料概要》等法律文件，了解基 金的风险收益特征，并根据自身的投资目的、投资期限、投资经验、资产状况等判断基金是否和您的风 险承受能力相适应。 投资人应当充分了解基金定期定额投资和零存整取等储蓄方式的区别。定期定额投资是引导投资人进行 长期投资、平均投资成本的一种简单易 ...

Group 1: Fund Management Changes - Lin Qing has resigned as the Deputy General Manager of Zhongke Wotu Fund due to personal reasons, effective December 9, and the change has been approved by the board [1] - Over 50 public fund companies have experienced changes in senior management, including chairpersons or general managers, accounting for approximately 30% of the total public fund companies this year [3] Group 2: Fundraising and Investment Opportunities - Pengyang Fund has announced an early closure of the fundraising period for its Pengyang Hong Kong Stock Connect Selected Mixed Fund, moving the deadline from January 19, 2026, to December 12, 2023 [2] - Robeco Fund has also advanced the fundraising deadline for its Robeco Hong Kong Stock Connect Technology Equity Fund from March 6, 2026, to December 26, 2023 [2] Group 3: ETF Market Performance - The market experienced a downturn with the Shanghai Composite Index falling by 0.7%, the Shenzhen Component Index by 1.27%, and the ChiNext Index by 1.41%, with a total trading volume of 1.86 trillion yuan, an increase of 786 billion yuan from the previous trading day [4] - The satellite ETF sector showed resilience, with several satellite ETFs experiencing gains, including a 1.48% increase for the Yifangda Satellite ETF [5][6] Group 4: Thematic Investment Opportunities - China is entering a phase similar to SpaceX's network development from 2018 to 2020, with satellite manufacturing transitioning from custom lab designs to mass production [7] - Companies providing standardized power, communication, and attitude control systems are expected to see performance improvements, making satellite ETFs and related products worth monitoring [7]